Most drug industry stakeholders agree that FDA needs additional funding to regulate the OTC sector and make more self-care products available, but some need convincing the agency is on the right track looking at a potential user fee for the OTC monograph program.
At a June 10 public meeting, Center for Drug Evaluation and Research Director Janet Woodcock and other officials explained the...